Showing 631-640 of 9658 results for "".
Saving Medical Dermatology: Biologics and the Future of Patient Care
https://practicaldermatology.com/topics/practice-management/saving-medical-dermatology-biologics-and-the-future-of-patient-care/21211/Although prescription rates lag, biologic agents may hold the key to sustaining the specialty.2014 Year in Review: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-skin-cancer/19001/Gary Goldenberg, MD offers a snapshot look at the newest therapies in the skin cancer treatment landscape, as well as the newest innovations across various disease states in the specialty.Customize Online Content to Suit Your Target Audience
https://practicaldermatology.com/topics/practice-management/customize-online-content-to-suit-your-target-audience/21256/You can generate maximum impact for your practice when you create customized content with a sharp focus on your target audience.Ask an Expert: Sheila Fallon Friedlander, MD on the Molluscum Pipeline
https://practicaldermatology.com/topics/general-topics/ask-an-expert-sheila-fallon-friedlander-md-on-the-molluscum-pipeline/19006/Sheila Fallon Friedlander, MD talks to host Adam Friedman, MD about the pipeline of treatments for molluscum in pediatric patients. From NewDermMD.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.Understanding Sublative Therapy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-sublative-therapy/19056/What is sublative? Michael H. Gold, MD explains how the technology works and how it fits in practice.Injectable Safety
https://practicaldermatology.com/topics/practice-management/injectable-safety/19042/Steve Yoelin, MD discusses injectable safety, risks associated with fillers and neurotoxins, and a novel approach to training for injectors.Save Money; Don't Sacrifice Staff
https://practicaldermatology.com/topics/practice-management/save-money-don-t-sacrifice-staff/19079/Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions warn against the common mistake of cutting back on or not investing in staff. There are better ways to save money without hurting your practice.Controversies in Mohs Surgery
https://practicaldermatology.com/topics/skin-cancer-photoprotection/controversies-in-mohs-surgery/19129/Joel Schlessinger, MD discusses the changing landscape of Mohs surgery for skin cancer. Specifically he addresses turf wars among professional organizations.DermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.